922
Views
7
CrossRef citations to date
0
Altmetric
Review

Therapeutic choices in convulsive status epilepticus

, MD (Epilepsy Fellow) & , MD (Associate Professor of Neurology)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Antonella Riva, Giulia Lapadre, Eleonora Agata Grasso, Ganna Balagura, Pasquale Striano & Alberto Verrotti. (2021) Intramuscular Midazolam for treatment of Status Epilepticus. Expert Opinion on Pharmacotherapy 22:1, pages 37-44.
Read now
Monika Popławska, Kinga K Borowicz & Stanisław J Czuczwar. (2015) The safety and efficacy of fosphenytoin for the treatment of status epilepticus. Expert Review of Neurotherapeutics 15:9, pages 983-992.
Read now

Articles from other publishers (5)

Zhan-Miao Yi, Xu-Li Zhong, Ming-Lu Wang, Yuan Zhang & Suo-Di Zhai. (2020) Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Marta Amengual-Gual, Iván Sánchez Fernández & Mark S. Wainwright. (2019) Novel drugs and early polypharmacotherapy in status epilepticus. Seizure 68, pages 79-88.
Crossref
. 2018. Sedation. Sedation 14 22 .
Xuefeng Wang & Shichuo Li. 2017. Refractory Status Epilepticus. Refractory Status Epilepticus 197 246 .
Zi-yu Zhao, Hong-ying Wang, Bin Wen, Zhi-bo Yang, Kang Feng & Jing-chun Fan. (2016) A Comparison of Midazolam, Lorazepam, and Diazepam for the Treatment of Status Epilepticus in Children. Journal of Child Neurology 31:9, pages 1093-1107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.